Research
Hormonal
Curcumin supplementation significantly reduces fasting blood glucose, glycated hemoglobin (HbA1c), and body mass index in patients with Type 2 Diabetes Mellitus.
If you have Type 2 Diabetes, adding curcumin to your routine may help lower your blood sugar and HbA1c. Look for high-bioavailability forms like nano-curcumin or curcumin paired with piperine, taken daily for at least 8 weeks, while continuing your standard diabetes medications.
GoodSupportsHIGH confidence
The results showed that curcumin’s anti-diabetic activity might be due to its capacity to suppress oxidative stress and inflammatory process. Also, it significantly reduces fasting blood glucose, glycated hemoglobin, and body mass index.
Why this rating
Based on a systematic review of 16 studies, including multiple randomized double-blind placebo-controlled trials.
Source
The Effects of Curcumin on Diabetes Mellitus: A Systematic Review
Ledyane Taynara Marton et al. · Frontiers in Endocrinology · 2021
DOI 10.3389/fendo.2021.669448
systematic_review · n=1309Cited 202×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Curcumin supplementation improves lipid profiles in Type 2 Diabetes patients by significantly reducing triglycerides, total cholesterol, LDL cholesterol, and VLDL cholesterol, while increasing HDL cholesterol.Good
- Curcumin reduces oxidative stress and inflammation in Type 2 Diabetes patients, as evidenced by reduced levels of Malondialdehyde (MDA) and C-Reactive Protein (CRP).Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →